CTRI/2012/10/003055进行中（未招募）3 期
Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer
Amgen Technology Pvt Ltd0 个研究点目标入组 400 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subject was previously enrolled in a denosumab phase three study and participated in the Open label Extension portion of that study.
- •Subject or subjects legally acceptable representative has provided informed consent.
排除标准
- •Subject is of child bearing potential and planning to become pregnant within 7 months after the end of treatment.
- •Subject is of child bearing potential and is not willing to use, in combination with her partner, two highly effective methods of contraception during treatment and for 7 months after the end of treatment.
- •Subject has known sensitivity to any of the products to be administered during dosing.
- •Subject will not be available for protocol required study visits or procedures, to the best of the subject and investigators knowledge.
- •Subject has any kind of disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and or to comply with all required study procedures.
研究者
相似试验
进行中（未招募）
1 期
Open-Label Access Protocol of Denosumab for Subjects with Advanced CancerBone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate CancerMedDRA version: 14.1 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 100000004864MedDRA version: 14.1 Level: LLT Classification code 10005993 Term: Bone metastases System Organ Class: 100000004864MedDRA version: 14.1 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 100000004864EUCTR2011-002114-36-BEAmgen Inc129
进行中（未招募）
不适用
Open-Label Access Protocol of Denosumab for Subjects with Advanced CancerBone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate CancerMedDRA version: 16.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: LLTClassification code 10005993Term: Bone metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: PTClassification code 10062904Term: Hormone-refractory prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002114-36-LTAmgen Inc168
进行中（未招募）
1 期
Open-Label Access Protocol of Denosumab for Subjects with Advanced CancerBone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate CancerMedDRA version: 16.0 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0 Level: LLT Classification code 10005993 Term: Bone metastases System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002114-36-HUAmgen Inc129
进行中（未招募）
1 期
Open-Label Access Protocol of Denosumab for Subjects with Advanced CancerBone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate CancerMedDRA version: 14.0 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.0 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.0 Level: LLT Classification code 10005993 Term: Bone metastases System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002114-36-ESAmgen Inc129
进行中（未招募）
1 期
Open-Label Access Protocol of Denosumab for Subjects with Advanced CancerEUCTR2011-002114-36-PLAmgen Inc129